{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:44:05Z","timestamp":1763052245446,"version":"3.45.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.7759\/cureus.96773","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:41:07Z","timestamp":1763052067000},"source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab-Induced Myalgia and Enthesitis in a Pediatric Patient Treated for Severe Atopic Dermatitis"],"prefix":"10.7759","author":[{"given":"Mohamad","family":"Sabsabee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheikha","family":"Alketbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Al Hamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nasreldien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0243-4","article-title":"A systematic scoping literature review of publications supporting treatment guidelines for pediatric atopic dermatitis in contrast to clinical practice patterns","volume":"8","author":"Siegfried EC","year":"2018","unstructured":"Siegfried EC, Jaworski JC, Mina-Osorio P. A systematic scoping literature review of publications supporting treatment guidelines for pediatric atopic dermatitis in contrast to clinical practice patterns. Dermatol Ther (Heidelb). 2018, 8:349-77. 10.1007\/s13555-018-0243-4","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040634","article-title":"Dupilumab in inflammatory skin diseases: a systematic review","volume":"13","author":"Olbrich H","year":"2023","unstructured":"Olbrich H, Sadik CD, Ludwig RJ, Tha\u00e7i D, Boch K. Dupilumab in inflammatory skin diseases: a systematic review. Biomolecules. 2023, 13:4-6. 10.3390\/biom13040634","journal-title":"Biomolecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt A","year":"2017","unstructured":"Blauvelt A, de Bruin-Weller M, Gooderham M, et al.. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017, 389:2287-303. 10.1016\/S0140-6736(17)31191-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.025","article-title":"Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: a US nationwide cohort study","volume":"90","author":"Schneeweiss MC","year":"2024","unstructured":"Schneeweiss MC, Wyss R, Schneeweiss S, et al.. Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: a US nationwide cohort study. J Am Acad Dermatol. 2024, 90:134-7. 10.1016\/j.jaad.2023.08.025","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.08.127","article-title":"Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry","volume":"84","author":"Ari\u00ebns LF","year":"2021","unstructured":"Ari\u00ebns LF, van der Schaft J, Spekhorst LS, et al.. Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry. J Am Acad Dermatol. 2021, 84:1000-9. 10.1016\/j.jaad.2020.08.127","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.12.011","article-title":"Review of dupilumab-associated inflammatory arthritis: an approach to clinical analysis and management","volume":"21","author":"Jay R","year":"2022","unstructured":"Jay R, Rodger J, Zirwas M. Review of dupilumab-associated inflammatory arthritis: an approach to clinical analysis and management. JAAD Case Rep. 2022, 21:14-8. 10.1016\/j.jdcr.2021.12.011","journal-title":"JAAD Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb H","year":"2020","unstructured":"Harb H, Chatila TA. Mechanisms of dupilumab. Clin Exp Allergy. 2020, 50:5-14. 10.1111\/cea.13491","journal-title":"Clin Exp Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.11.020","article-title":"Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis","volume":"74","author":"Astry B","year":"2015","unstructured":"Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine. 2015, 74:54-61. 10.1016\/j.cyto.2014.11.020","journal-title":"Cytokine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101520","article-title":"Unexpected connections of the IL-23\/IL-17 and IL-4\/IL-13 cytokine axes in inflammatory arthritis and enthesitis","volume":"58","author":"Bridgewood C","year":"2021","unstructured":"Bridgewood C, Newton D, Bragazzi N, Wittmann M, McGonagle D. Unexpected connections of the IL-23\/IL-17 and IL-4\/IL-13 cytokine axes in inflammatory arthritis and enthesitis. Semin Immunol. 2021, 58:101520. 10.1016\/j.smim.2021.101520","journal-title":"Semin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/410966-dupilumab-induced-myalgia-and-enthesitis-in-a-pediatric-patient-treated-for-severe-atopic-dermatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:41:08Z","timestamp":1763052068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/410966-dupilumab-induced-myalgia-and-enthesitis-in-a-pediatric-patient-treated-for-severe-atopic-dermatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.96773","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}